Drug recall · October 21, 2020
Cystaran recall
Why: Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01
- Lots / codes
Lot #: 370655, Exp. 10/31/2020
- Quantity
- 1380 bottles
- Company
- Leadiant Biosciences, Inc., Gaithersburg, MD
- Distribution
- PA and Italy
- Initiated
- September 24, 2020 · Voluntary: Firm initiated
- Classified
- October 15, 2020
- Reported
- October 21, 2020
- Ended
- November 10, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.